Adeno-associated viral vectors for gene therapy

Biogenic Amines

Volumn 14, Issue 5, 1998, Pages 451-475

  Summerford, C ^a   Samulski, R J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

AAV; Gene therapy; Heparan sulfate proteoglycan; rAAV; Viral vectors

Indexed keywords

ERYTHROPOIETIN; HEPARAN SULFATE;

ADENO ASSOCIATED VIRUS; CELL DIVISION; DNA SYNTHESIS; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HEMOPHILIA B; IMMUNE RESPONSE; NONHUMAN; PARKINSON DISEASE; PLASMID; REVIEW; SEROTYPE; TRANSGENE; VIRION; VIRUS CELL INTERACTION; VIRUS RECOMBINANT;

EID: 0031718774     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Afione, S.A., conrad, C.K., Kearns, W.G., Chunduru, S., Adams, R., Reynolds, T.C., Guggino, W.B., Cutting, G.R., Carter, B.J. and Flotte, T.R. (1996). In vivo model of adeno-associated virus vector persitence and rescue. J. Virol., 70: 3235-3241.
2. Alexander, I.E., Russell, D.W. and Miller, A.D. (1994). DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol., 68: 8282-8287.
3. Alexander, I.E., Russle, D.W., Spence, A.M. and Miller, A.D. (1996). Effects of gama irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther., 7: 841-850.
4. Atchison, R.W., Castro, B.C. and Harnmond, W.M. (1965). Adeno-associated defective virus particles. Science, 149: 754-759.
5. Atha, D.H., Stephens, A.W., Rimon, A. and Rosenberg, R.D. (1984). Sequence variation in heparin octasaccharides with high affinity for antithrombin III. Biochemistry, 23: 5801-5812.
6. Bantel-Schaal, U. and Hausen, H.Z. (1984). Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology, 134: 52-63.
7. 2 antibody. (Submitted)
8. Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong, J.S., Horwitz, M.S., Crowell, R.L. and Finberg, R.W. (1997). Isolation of a Common Receptor for Coxsakie B viruses and Adenovirus 2 and 5 Science, 275: 1320-1323.
9. Berns, K.I. (1996). Parvoviridae, the viruses and their replication. In Fields Virology, Vol. 3, B.N. Fields, D.M. Knipe and P.M. Howley (Eds.), Lippencott-Raven, Philadelphia, pp. 2173-2197.
10. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. and Bonds, D.R. (1995). Effect of hydroxyurea on the frequency of painful sickle cell anemia. New Engl. J. Med., 332: 1317-1322.
11. Chen, Y., Maguire, T., Hileman, R.E., Fromm, J.R., Esko, J.D., Linhardt, R.J. and Marks, R.M. (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Med., 3: 866-871.
12. Chiang, M.K. and Flanagan, J.G. (1995). Interactions between FLK-1 receptor, vascular endothelial derived growth factor, and cell surface proteoglycan identified with a souble receptor reagent. Growth Factors, 12: 1-10.
13. Chiorini, J.A., Yang, L., Liu, Y., Safer, B. and Kotin, R.M. (1997). Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J. Virol., 71: 6823-6833.
14. Clark, K.R., Voulgaropoulou, F., Fraley, D.M. and Johnson, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther., 6: 1329-1341.
15. Compton, T., Nowlin, D.M. and Cooper, N.R. (1993). Initiation of human cytomegleovirus infection requires initial interaction with cell surface heparan sulfate. Virology, 193: 834-841.
16. Diertrich, C.P. and Cassaro, C.M.F. (1977). Distribution of sulfated mucopolysaccharides in invertebrates. J. Biol. Chem., 252: 2254-2261.
17. During, M., Samulski, R.J., Elsworth, J.D., Kaplitt, M.G., Leone, P., Xiao, X., Li, J., Freese, A., Taylor, J.R., Roth, R.H., Sladek, J.R., O'Malley, K.L. and Redmond, D.E. (1998). In vivo expression of therapeutic genes for dopamine production in caudates of MPTP-treated monkeys using an AAV vector. Gene Ther. (in the press).
18. Dyer, A.P., Banfield, B.W., Martindale, D., Spannier, D. and Tufaro, F. (1997). Dextran sulfate can act as an artificial receptor to mediate a type-specific herpes simplex virus infection via glycoprotein B. J. Virol., 71: 191-198.
19. Ferran, F.K., Samulski, T., Shenk, T. and Samulski, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol., 7: 3277-3234.
20. Ferrari, F.K., Xiao, X., McCarty, D. and Samulski, R.J. (1997). New developments in the generation of Adfree high titer rAAV gene therapy vectors. Nature med., 3: 1295-1297.
21. Feyzi, E., Trybla, E., Bergstrom, T., Lindahl, U. and Spillman, D. (1997). Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein c. J. Biol. Chem., 272: 24850-24857.
22. Fisher, K.J., Gao, G.P., Weitzman, M.D., DeMatteo, R., Burda, J.F. and Wilson, J.M. (1996). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol., 70: 520-532.
23. Fisher, K.J., Jooss, K., Alston, J., Yang, Y., Haecker, S.E., High, K., Pathak, R., Raper, S.E. and Wilson, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med., 3: 306-312.
24. + human hematopoetic progenitor cells after transduction. Blood, 88: 492-504.
25. Flannery, J.G., Zolotukhin, M., Vaquero, M.I., Lavail, M.M., Muzyczka, N. and Hauswirth, W.W. (1997). Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA, 94: 6916-6921.
26. Flotte, T.R. and Carter, B.J. (1997). Cystic Fibrosis Foundation Williamsburg Gene Therapy Conference
27. Flotte, T., Carter, B., Conrad, C., Guggino, W., Reynolds, T., Rosenstein, B., Taylor, G., Walden, S. and Wetzel, R. (1996). Phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther., 7: 1145-1159.
28. Flotte, T.R., Afione, S.A., Conrad, C., McGrath, S.A., Solow, R., Oka, H., Zeitlin, P.L., Guggino, W.B. and Carter, B.J. (1993). Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA, 90: 10613-10617.
29. Flotte, T.R., Carter, B.J. (1995). Adeno-associated virus vectors for gene therapy. Gene ther., 2: 357-362.
30. Frye, G.D., McCown, T.J. and Breese, G.R. (1983). GABA mimetic blockade of ethanol withdrawl-audiogenic seizures of the inferior colliculus:comparison with the substantia nigra and medical septum. J. Pharmacol. Exp. Ther., 227: 663-669.
31. Fuller, A.O., Santos, R.E. and Spear, P.O. (1989). Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. J. Virol., 63: 3435-3443.
32. Gnatenko, D., Arnold, T.E., Zolotukhin, S., Nuovo, G.J., Muzyczka, N. and Bahou, W.F. (1997). Characterization of recombinant adeno-associated virus-2 as a vehicle for gene delivery and expression into vascular cells. J. Inves. Med., 45: 87-98.
33. Goodman, S., Xiao, X., Donahue, R.E., Moulton, A., Miller, J., Walsh, C., Young, N.S., Samulski, R.J. and Nienhuis, A.W. (1994). Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood, 84: 1492-1500.
34. Herold, B.C., Gerber, S.I., Belval, B.J., Siston, A.M. and Shulman, N. (1996). Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. J. Virol., 70: 3461-3469.
35. Herold, B.C., Gerber, S.I., Polonsky, T., Belval, B.J., Shaklee, P.N. and Holme, K. (1995). Identification of structural features of heparin required for inhibition of herpes simplex virus type I binding. Virology, 206: 1108-1116.
36. Herzog, R.W., Hagstrom, J.N., Kung, S.H., Tai, S.J., Wilson, J.M., Fisher, K.J. and High, K.A. (1997). Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA, 94: 5804-5809.
37. Hoggan, M.D., Blacklow, N.R. and Rowe, W.P. (1966). Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc. Natl. Acad. Sci. USA, 55: 1457-1471.
38. Holscher, C., Horer, M., Kleinschmidt, J.A., Zentgraf, H., Burkle, A. and Heilbronn, R. (1994). Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants. J. Virol., 68, 7169-7177.
39. Jackson, R.L., Busch, S.J. and Cardin, A.D. (1991). Glycosaminoglycans: molecular propeties, protein interactions, and role in physiological processes. Physiol. Reviews, 71, 481-539.
40. Jackson, T., Ellard, F.M., Ghazaleh, R.A., Brookes, S.M., Blakemore, W.E., Corteyn, A.H., Stuart, D.I., Neewman, J.W. I and King, A.M. (1996). Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol., 70: 5282-5287.
41. Kaburn, N., Buhring, H.J., Choi, K., Ulrich, A., Risau, W. and Kerler, G. (1997). FLK-1 expression defines a population of early embryonic hematopoetic precursors. Development, 124: 2039-2048.
42. Kaplitt, M.G., Leone, P., Samulski, R.J., Xiao, X., Pfaff, D.W., O'Malley, K.L. and During, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet., 8: 148-154.
43. Kaplitt, M.G., Xiao, X., Samulski, R.J., Li, J., Ojamaa, K., Klein, I., Makimura, H., Kaplitt, M.J., Strumpf, R.K. and Diethrich, E.B. (1996). Long-term gene transfer in porcine myocardium after coronary infusion of adeno-associated virus vector. Ann. Thrac. Surg., 62: 1669-1676.
44. Kessler, P.D., Podsakoff, G.M., Chen, X., McQuiston, S.A., Colosi, P.C., Matelis, L.A., Kurtzmann, G.J. and Byrne, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA, 93: 14082-14087.
45. Kjellen, L. and Lindahl, U. (1991). Proteoglycans: structures and interactions. Annu. Rev. Biochem., 60: 443-475.
46. Koeberl, D.D., Alexander, I.E., Halbert, C.L., Russell, D.W. and Miller, A.D. (1997). Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA, 94: 1426-1431.
47. Kotin, R.M., (1994). Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. gene Ther., 5, 793-801.
48. Laughlin, C.A., Tratschin, J.D., Coon, H. and Carter, B.J. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene, 23: 65-73.
49. Li, J., Samulski, R.J. and Xiao, X. (1997). Role of highly regulated rep gene expression in adeno-associated virus vector production. J. Virol., 71: 5236-5243.
50. Lindahl, U., Backstrom, G., Thunberg, L. and Leder, I.G. (1980). Evidence for a 3-O-sulfated D-glucosamine residue in the anti-thrombm-binding sequence of heparin. Proc. Natl. Acad. Sci. USA, 77: 6551-6555.
51. Linhardt, R.J., Cooney, C.L. and Galliher, P.M. (1986). Polysaccharide Lyases. Appl. Biochem. Biotechnol., 12: 135-177.
52. Lycke, E., Johansson, M., Svennerholm, B. and Lindah, U. (1991). Binding of herpes simplex virus to cellular heparan sulfate, an initial step in the adsorption process. J. Gen. Virol., 72: 1131-1137.
53. Maccarana, M., Casu, B. and Lindahl, U. (1993). Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem., 268: 23898-23905.
54. Mandel, R.J., Spratt, S.K., Snyder, R.O. and Leff, S.E. (1997). Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA, 94: 14083-14088.
55. McCown, T., Xiao, X., Li, J., Breese, G. and Samulski, R. (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res., 713: 99-107.
56. McCown, T.J., Givens, B.S. and Breese, G.R. (1987). Amino acid influences on seizures elicited within the inferior colliculus. J. Pharmacol. Exp. Ther., 243: 603-608.
57. Miller, A.D. (1996). Cell-surface receptors for retroviruses and implications for gene transfer. Proc. Natl. Acad. Sci. USA, 93: 11407-11413.
58. Mizukami, H., Brown, K.E. and Young, N. (1996). Adeno-Associated Virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology, 217: 124-130.
59. Monahan, P.E., Tazelaar, J., Xiao, X., Nichols, T.C., Bellinger, D.A., Read, M.S., Walsh, C.E. and Samulski, R.J. (1998). Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther., 5: 40-49.
60. Montgomery, R.I., Warner, M.S., Lurn, B.J. and Spear, P.G. (1996). Herpes Simplex Virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell, 87: 427-436.
61. Muramatsu, S., Mizukami, H., Young, N.S. and Brown, K.E. (1996). Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology, 221: 208-217.
62. Murphy, J.E., Zhou, S., Giese, K., Williams, L.T., Escobedo, J.A. and Dwarki, V.J. (1997). Long-term correction of obesity and diabetes in genetically obese mice by single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc. Natl. Acad. Sci. USA, 94: 13921-13926.
63. Muzyczka, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells Curr.Top. Microbiol. Immunol., 158: 97-129.
64. Parks, W.P., Melnick, J. L., Rongey, R. and Mayor, H. D. (1967). Physical assay and growth cycle studies of a defective adeno-satelhte virus. J. Virol., 1, 171-180.
65. Peel, A.L., Zolotukhin, S., Schrimscher, G.W. and Muzycka, N. (1997). Efficient transduction of green fluorescent protein in spinal chord neurons using adeno-associated virus vectors containing cell type specific promoters. Gene Ther., 4: 16-24.
66. Pell, A.L., Zolotukhin, S., Schrimsher, G.W., Muzyczka, N. and Reier, P.J. (1997). Efficient transduction of green fluorescent protein in spnal chord neurons using adeno-associated virus containing cell type specific promoters. Gene Ther., 4: 16-24.
67. + hematopoetic progenitor cells donor variation and correlation of transgene expression with cellular differentiation. J. Virol., 71: 8262-8267.
68. Ponnazhagan, S., Mukherjee, P., Yoder, M.C., Wang, X.S., Zhou, S.Z., Kaplan, J., Wadsworth, S. and Srivastava, A. (1997b). Adeno-associated virus 2 mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene, 190: 203-210.
69. Ponnazhagan, S., Wang, X., Woody, M.J., Luo, F., Kang, L.Y., Madahavi, L.N., Munshi, C.M., Shang, Z.Z. and Srivasta, A. (1996). Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megacaryocytic leukaemia cells are non-permissive for AAV infection. J. Gen. Virol., 77: 1111-1122.
70. Qing, K., Khuntirait, B., Mah, C., Kube, D.M., Wang, X., Ponnazhagan, S., Zhou, S., Dwarki, V., Yoder, M.C. and Srivasava, A. (1998). Adeno-associated type 2-mediated gene transfer: correlation of tyrosine phophorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol., 72: 1593-1599.
71. Qing, K., Wang, X., Kube, D., Ponnazhagan, S., Bajpai, A. and Srivastava, A. (1997). Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc. Natl. Acad. Sci. USA, 94: 10879-10884.
72. Roghani, M. and Moscatelli, D. (1992). Basic Fibroblast Growth Factor is internalized through both receptor-mediated and heparan sulfate mediated mechanisms. J. Biol. Chem., 267: 22156-22162.
73. Rostand, K.S. and Esko, J.D. (1997). Microbial adherence and invasion through proteoglycans. Infect. Immun., 65: 1-8.
74. Russell, D.W., Alexander, I.A. and Miller, A.D. (1995). DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associaied virus vectors. Proc. Natl. Acad. Sci. USA, 92: 5719-5723.
75. Rutledge, E.A., Halbert, C.L. and Russle, D.W. (1998). Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol., 72: 309-319.
76. Samulski, R.J., Berns, K.I., Tan, M. and Muzyczka, N. (1982). Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA, 79: 2077-2081.
77. Samulski, R.J., Chang, L.S. and Shenk, T. (1987)., A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol., 61: 3096-3101.
78. Samulski, R.J., Chang, L.S. and Shenk, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol., 63: 3822-3828.
79. Samulski, R.J., Srivastava, A., Berns, K.I. and Muzyczka, N. (1983). Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell, 33: 135-143.
80. Samulski, R.J. (1995). Adeno-associated virus-based vectors for human gene therapy. In: Gene therapy from laboratory to clinic, K.M. Hui (Ed.), World Scientific Publishing Co., Singapore, pp. 232-271.
81. Samulski, R.J. (1997). Development of adeno-associated virus as a vector for human gene therapy. In: Transgenic animals: generation and use, L.M. Houdebine (Ed.), Harwood Academic Publishers, pp. 197-203.
82. Saxena, U., Klein, M.G. and Goldberg, I.J. (1990). Metabolism of endothelial cell-bound lipoprotein lipase. J. Biol. Chem., 265: 12880-12886.
83. Sheih, M., Montgomery, R.I., Esko, J.D. and Spear, P. (1992). Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol., 116: 1273-1281.
84. Shishido, Y., Sharma, K., Higashiyama, S., Klagsbrun, M. and Mekada, E. (1995). Heparin-like molecules on the cell surface potentiate binding of diptheria toxin receptor/membrane-anchored heparin binding epidermal growth factor-like growth factor. J. Biol. Chem., 270: 29578-29585.
85. Smith, F.E. and McCown, T.J. (1997). In: Gene transfer and therapy for neurological disorders, E.A. Chiocca and X.O. Breakefield (Eds.), Humana Press, pp. 79-88.
86. Snyder, R., Miao, C., Patijn, G., Spratt, S., Danos, O., Nagy, D., Gown, A., Winter, B., Meuse, L., Cohen, L., Thompson, A. and Kay, M. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet., 16: 270-276.
87. Snyder, R.O., Xiao, X. and Samulski, R.J. (1996). Production of recombinant adeno-associated virus vectors. In: Current protocols in Human Genetics, N. Dracopoli, J. Haines, B. Krof, D. Moir, C. Seidman and J. Seichman (Eds.), John Wiley, New York, pp. 12.1.1-12.2.23.
88. Summerford, C. and Samulski, R.J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 vinons. J. Virol., 72: 1438-1445.
89. Trempe, J.P. and Yang, Q. (1993). Fifth Parvovirus Workshop, Crystal River, FL.
90. Trybala, E., Bergestrom, T., Spillman, D., Svennerholm, B., Flynn, S.J. and Ryan, P. (1998). Interaction between psuedorabies virus and heparin/heparan sulfate. J. Biol. Chem., 273: 5047-5052.
91. Trybala, E., Bergestrom, T., Spillman, D., Svennerholm, B., Olofsson, S., Flynn, S.J. and Ryan, P. (1996). Mode of interaction between pseudorabies virus and heparan sulfate/heparin. Virology, 218: 35-42.
92. Vincent, K.A., Piraino, S.T. and Wadsworth, S.C. (1997). Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol., 71, 1897-1905.
93. Wicham, T.J., Mathias, P., Cheresh, D.A. and Nemerow, G.R. (1993). Integrins αVβ3 and αVβ5 promote adenovirus internalization but not virus attachmemt. Cell, 73: 309-319.
94. WuDunn, D. and Spear, P. (1989). Initial interaction of Herpes Simplex Virus with cells is binding to heparin sulfate. J. Virol., 63: 52-58.
95. Xiao, X., Juan, L. and Samulski, R. (1996a). Efficient long-term gene transfer into muscle of immunocompetent mice by adeno-associated virus vector. J. Virol., 70: 8098-8108.
96. Xiao, X., Li, J. and Samulski, R.J. (1996b). Efficient long term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol., 70: 8098-8108.
97. Xiao, X., Li, J. and Samulski, R.J. (1998). Production of high titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol., 72: 2224-2232.
98. Xiao, X., McCown, T.J., Li, J., Breese, G.R., Morrow, A.L. and Samulski, R.J. (1997). Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABA(A) alpha1 containing receptors and increases inferior collicular seizure sensitivity. Brain Res., 756: 76-83.
99. Yang, Y., Li, Q., Ertl, H.C. and Wilson, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol., 69: 2004-2015.
100. Yang, Y., Nunes, F.A., Berencsi, K., Furth, E.E., Gonczol, E. and Wilson, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA, 91: 4407-4411.
101. + CTLs in vivo. J. Immunol., 155: 2564-2570.